These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25366989)

  • 1. Genomic mapping of the MHC transactivator CIITA using an integrated ChIP-seq and genetical genomics approach.
    Wong D; Lee W; Humburg P; Makino S; Lau E; Naranbhai V; Fairfax BP; Chan K; Plant K; Knight JC
    Genome Biol; 2014; 15(10):494. PubMed ID: 25366989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
    Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
    J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation.
    Zika E; Greer SF; Zhu XS; Ting JP
    Mol Cell Biol; 2003 May; 23(9):3091-102. PubMed ID: 12697811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide CIITA-binding profile identifies sequence preferences that dictate function versus recruitment.
    Scharer CD; Choi NM; Barwick BG; Majumder P; Lohsen S; Boss JM
    Nucleic Acids Res; 2015 Mar; 43(6):3128-42. PubMed ID: 25753668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation.
    Hake SB; Masternak K; Kammerbauer C; Janzen C; Reith W; Steimle V
    Mol Cell Biol; 2000 Oct; 20(20):7716-25. PubMed ID: 11003667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma.
    Piskurich JF; Gilbert CA; Ashley BD; Zhao M; Chen H; Wu J; Bolick SC; Wright KL
    Mol Immunol; 2006 Feb; 43(6):519-28. PubMed ID: 15950283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NLRC5 exclusively transactivates MHC class I and related genes through a distinctive SXY module.
    Ludigs K; Seguín-Estévez Q; Lemeille S; Ferrero I; Rota G; Chelbi S; Mattmann C; MacDonald HR; Reith W; Guarda G
    PLoS Genet; 2015 Mar; 11(3):e1005088. PubMed ID: 25811463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells.
    Butticè G; Miller J; Wang L; Smith BD
    Circ Res; 2006 Mar; 98(4):472-9. PubMed ID: 16439692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major histocompatibility class II transactivator (CIITA) mediates repression of collagen (COL1A2) transcription by interferon gamma (IFN-gamma).
    Xu Y; Wang L; Butticè G; Sengupta PK; Smith BD
    J Biol Chem; 2004 Oct; 279(40):41319-32. PubMed ID: 15247294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.
    Masternak K; Reith W
    EMBO J; 2002 Mar; 21(6):1379-88. PubMed ID: 11889043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes.
    Villard J; Muhlethaler-Mottet A; Bontron S; Mach B; Reith W
    Int Immunol; 1999 Mar; 11(3):461-9. PubMed ID: 10221658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation, Promoter Recruitment and Transactivation Mediated by the Extreme N-Terminus of MHC Class II Transactivator CIITA Isoform III.
    Beaulieu YB; Leon Machado JA; Ethier S; Gaudreau L; Steimle V
    PLoS One; 2016; 11(2):e0148753. PubMed ID: 26871568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex.
    Masternak K; Muhlethaler-Mottet A; Villard J; Zufferey M; Steimle V; Reith W
    Genes Dev; 2000 May; 14(9):1156-66. PubMed ID: 10809673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay among coactivator-associated arginine methyltransferase 1, CBP, and CIITA in IFN-gamma-inducible MHC-II gene expression.
    Zika E; Fauquier L; Vandel L; Ting JP
    Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16321-6. PubMed ID: 16254053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of MHC II genes.
    Drozina G; Kohoutek J; Jabrane-Ferrat N; Peterlin BM
    Curr Top Microbiol Immunol; 2005; 290():147-70. PubMed ID: 16480042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The S box of major histocompatibility complex class II promoters is a key determinant for recruitment of the transcriptional co-activator CIITA.
    Muhlethaler-Mottet A; Krawczyk M; Masternak K; Spilianakis C; Kretsovali A; Papamatheakis J; Reith W
    J Biol Chem; 2004 Sep; 279(39):40529-35. PubMed ID: 15271997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcription factor RFX protects MHC class II genes against epigenetic silencing by DNA methylation.
    Seguín-Estévez Q; De Palma R; Krawczyk M; Leimgruber E; Villard J; Picard C; Tagliamacco A; Abbate G; Gorski J; Nocera A; Reith W
    J Immunol; 2009 Aug; 183(4):2545-53. PubMed ID: 19620312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus LMP2A suppresses MHC class II expression by regulating the B-cell transcription factors E47 and PU.1.
    Lin JH; Lin JY; Chou YC; Chen MR; Yeh TH; Lin CW; Lin SJ; Tsai CH
    Blood; 2015 Apr; 125(14):2228-38. PubMed ID: 25631773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter.
    Chen H; Gilbert CA; Hudson JA; Bolick SC; Wright KL; Piskurich JF
    Mol Immunol; 2007 Feb; 44(6):1461-70. PubMed ID: 16765445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAC2 deacetylates class II transactivator and suppresses its activity in macrophages and smooth muscle cells.
    Kong X; Fang M; Li P; Fang F; Xu Y
    J Mol Cell Cardiol; 2009 Mar; 46(3):292-9. PubMed ID: 19041327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.